NCT02537314View on ClinicalTrials.gov

Role of the Foregut in Nutrient Metabolism in Lean and Obese Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 8, 2022

Study Completion Date

December 8, 2022

Conditions
Obesity
Interventions
DRUG

benzocaine

0.5% benzocaine solution in saline/hydrochloric acid administered by intraduodenal infusion one time (6 ml bolus followed by 75 ml/hour for 105 minutes)

OTHER

placebo

Placebo (saline) solution administered by intraduodenal infusion one time (6 ml bolus followed by 75 ml/hour for 105 minutes)

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Vanderbilt University Medical Center

OTHER

NCT02537314 - Role of the Foregut in Nutrient Metabolism in Lean and Obese Humans | Biotech Hunter | Biotech Hunter